Skip to search form
Skip to main content
Skip to account menu
Semantic Scholar
Semantic Scholar's Logo
Search 225,206,857 papers from all fields of science
Search
Sign In
Create Free Account
KRP 197
Known as:
KRP-197
National Institutes of Health
Create Alert
Alert
Related topics
Related topics
1 relation
Broader (1)
imidafenacin
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
2011
2011
In vivo bladder selectivity of imidafenacin, a novel antimuscarinic agent, assessed by using an effectiveness index for bladder capacity in rats
T. Yamazaki
,
Yukiko Muraki
,
Tsuyoshi Anraku
Naunyn-Schmiedeberg's Archives of Pharmacology
2011
Corpus ID: 12077280
Imidafenacin (KRP-197) is a novel antimuscarinic agent for overactive bladder treatment. The inhibitory effect of imidafenacin on…
Expand
Highly Cited
2007
Highly Cited
2007
Effects of Imidafenacin (KRP-197/ONO-8025), a New Anti-cholinergic Agent, on Muscarinic Acetylcholine Receptors
Fumiyoshi Kobayashi
,
Yuichi Yageta
,
M. Segawa
,
S. Matsuzawa
Arzneimittelforschung
2007
Corpus ID: 21636454
Abstract Imidafenacin (CAS 170105-16-5, KRP-197, ONO-8025) is an antagonist for the muscarinic acetylcholine (ACh) receptor…
Expand
2003
2003
Pharmacological Effects of KRP-197 on the Human Isolated Urinary Bladder
S. Murakami
,
Masaki Yoshida
,
+6 authors
S. Ueda
Urologia internationalis
2003
Corpus ID: 24748588
KRP-197, 4-(2-methylimidazol-l-yl)-2,2-diphenylbutyramide, is a newly synthesized antimuscarinic drug, developed for the…
Expand
1999
1999
Synthesis and antimuscarinic activity of a series of 4-(1-Imidazolyl)-2,2-diphenylbutyramides: discovery of potent and subtype-selective antimuscarinic agents.
H. Miyachi
,
H. Kiyota
,
H. Uchiki
,
M. Segawa
Bioorganic & Medicinal Chemistry
1999
Corpus ID: 25274835
1998
1998
Novel imidazole derivatives with subtype-selective antimuscarinic activity (1).
H. Miyachi
,
H. Kiyota
,
M. Segawa
Bioorganic & Medicinal Chemistry Letters
1998
Corpus ID: 22496301
By clicking accept or continuing to use the site, you agree to the terms outlined in our
Privacy Policy
(opens in a new tab)
,
Terms of Service
(opens in a new tab)
, and
Dataset License
(opens in a new tab)
ACCEPT & CONTINUE